Latest NewsNov 4, 2024HiFiBiO Therapeutics Receives FDA Clearance of IND Application for HFB200604, a Best-in-Class BTLA Agonist Antibody for the Treatment of Inflammatory and Immunology Diseases All Filter By: Year2024202320222021202020192018201720162015May 16, 2016HiFiBiO SAS announces participation in next generation antibody therapeutics session along with Adimab, F-Star and Innovative Targeting Solutions at BioInternational 2016 in San Francisco, USAMar 23, 2016HiFiBiO is Recognized as an “Innovative Start-up Company” by French President Francois Hollande at the Inauguration of the Institute Pierre-Gilles de GennesNov 23, 2015HiFiBiO SAS to Report Results from the First Fully Integrated, Single-Cell Antibody Discovery Platform at IBC Antibody and Engineering Therapeutics 2015 ConferenceOct 27, 2015HiFiBiO’s next generation antibody discovery platform to be presented by Pfizer Inc. at PEGS Europe 2015Aug 13, 2015HiFiBiO SAS Achieves Milestone in Antibody Research Collaboration with Pfizer Inc.< 1 … 14 15 16 17 >
